However, the present study is only the second one that investigated PTX3 as a potential biomarker during malaria and revealed the potential of this molecule to distinguish SNCM and CM from UM cases, coma from impaired consciousness and conscious cases as well as fatal cases from patients who survived. Here, PTX3 is linked to malaria.